NCT00371111

To Compare Therapeutic Effect of Intravitreal Bevacizumab and Triamcinolone in Resistant Uveitic Cystoid Macular Edema

• Status: Unknown
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 40 (estimated)
• Sponsor: Shahid Beheshti University of Medical Sciences · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

Cystoid macular edema (CME) is one of the common causes of vision loss in patients with UveitiS .Triamcinolone has been effectively used in reducing CME and improving the vision. Also there are some documents which recommend Bevacizumab(avastin) could reduce macular edema. This study compare intravitreous injection of triamcinolone and avastin in patients with resistant uveitic cystoid macular edema.

Detailed description

This study compare intravitreous injection of triamcinolone and avastin in patients with resistant uveitic cystoid macular edema.

Conditions

• Resistant Cystoid Macular Edema

Interventions

Type	Name	Description
DRUG	Intravitreal injection of Triamcinolone	4 mg of Triamcinolone
DRUG	Intravitreal injection of Avastin	Injection of 1.25 mg of Avastin and

Timeline

• Start date: 2006-08-01
• Primary completion: 2008-05-01
• Completion: 2008-09-01
• First posted: 2006-09-01
• Last updated: 2008-07-30

Locations

1 site across 1 country: Iran